These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1438 related articles for article (PubMed ID: 19404054)
1. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054 [TBL] [Abstract][Full Text] [Related]
2. Indication and benefit of pelvic sidewall dissection for rectal cancer. Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749 [TBL] [Abstract][Full Text] [Related]
3. Is total mesorectal excision always necessary for T1-T2 lower rectal cancer? Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Saito Y; Watanabe M; Morita T; Hida J; Ueno M; Ono M; Yasuno M; Sugihara K Ann Surg Oncol; 2010 Apr; 17(4):973-80. PubMed ID: 19953330 [TBL] [Abstract][Full Text] [Related]
4. [Clinic study of lateral lymph node metastasis in advanced lower rectal cancer]. Wu ZY; Wan J; Yao Y; Zhao G; Du JL; Yang J Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):190-2. PubMed ID: 18683713 [TBL] [Abstract][Full Text] [Related]
5. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330 [TBL] [Abstract][Full Text] [Related]
6. Lateral lymph node dissection for lower rectal cancer. Shiozawa M; Akaike M; Yamada R; Godai T; Yamamoto N; Saito H; Sugimasa Y; Takemiya S; Rino Y; Imada T Hepatogastroenterology; 2007 Jun; 54(76):1066-70. PubMed ID: 17629040 [TBL] [Abstract][Full Text] [Related]
7. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166 [TBL] [Abstract][Full Text] [Related]
8. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Ueno M; Oya M; Azekura K; Yamaguchi T; Muto T Br J Surg; 2005 Jun; 92(6):756-63. PubMed ID: 15838895 [TBL] [Abstract][Full Text] [Related]
9. Patterns of lateral pelvic lymph node metastases and micrometastases for patients with lower rectal cancer. Wang C; Zhou ZG; Yu YY; Li Y; Lei WZ; Cheng Z; Chen ZX Eur J Surg Oncol; 2007 May; 33(4):463-7. PubMed ID: 17081722 [TBL] [Abstract][Full Text] [Related]
10. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063 [TBL] [Abstract][Full Text] [Related]
11. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection]. Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079 [TBL] [Abstract][Full Text] [Related]
12. Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method. Hida J; Yasutomi M; Fujimoto K; Maruyama T; Okuno K; Shindo K J Am Coll Surg; 1997 May; 184(5):475-80. PubMed ID: 9145067 [TBL] [Abstract][Full Text] [Related]
13. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer. Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501 [TBL] [Abstract][Full Text] [Related]
14. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y; Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948 [TBL] [Abstract][Full Text] [Related]
15. Metastasis to the sigmoid or sigmoid mesenteric lymph nodes from rectal cancer. Park IJ; Choi GS; Lim KH; Kang BM; Jun SH Ann Surg; 2009 Jun; 249(6):960-4. PubMed ID: 19474698 [TBL] [Abstract][Full Text] [Related]
16. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision. Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512 [TBL] [Abstract][Full Text] [Related]
18. [Lateral pelvic lymph node metastasis is an important prognostic factor for low rectal cancer]. Pan YS; Wan YL; Liu YC; Wang X; Wu T Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):984-7. PubMed ID: 19957807 [TBL] [Abstract][Full Text] [Related]
19. Who can get the beneficial effect from lateral lymph node dissection for Dukes C rectal carcinoma below the peritoneal reflection? Sato H; Maeda K; Maruta M; Masumori K; Koide Y Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S3-12. PubMed ID: 17106812 [TBL] [Abstract][Full Text] [Related]
20. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence. Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]